Pharmacological profile of RU 58642, a potent systemic antiandrogen for the treatment of androgen-dependent disorders

Journal of Steroid Biochemistry and Molecular Biology

Volumn 64, Issue 1-2, 1998, Pages 103-111

  Battmann, T ^a   Branche, C ^a   Bouchoux, F ^a   Cerede, E ^a   Philibert, D ^a   Goubet, F ^a   Teutsch, G ^a   Gaillard Kelly, M ^a  

^a SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

3 [4 CYANO 3 (TRIFLUOROMETHYL)PHENYL] 5,5 DIMETHYL 2,4 DIOXO 1 IMIDAZOLIDINE ACETONITRILE; ALDOSTERONE; ANDROGEN RECEPTOR; ANTIANDROGEN; BICALUTAMIDE; DEXAMETHASONE; FLUTAMIDE; HYDROXYFLUTAMIDE; NILUTAMIDE; PROGESTERONE; RU 58462; STEROID RECEPTOR; TESTOSTERONE PROPIONATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CASTRATION; CONTROLLED STUDY; DRUG RECEPTOR BINDING; IN VITRO STUDY; KIDNEY; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PROSTATE; RABBIT; RAT; SEMINAL VESICLE; SUBCUTANEOUS DRUG ADMINISTRATION; THYMUS; UTERUS;

ANDROGEN ANTAGONISTS; ANILIDES; ANIMALS; FLUTAMIDE; GENITAL DISEASES, MALE; GENITALIA, MALE; HYDANTOINS; IMIDAZOLES; IMIDAZOLIDINES; MALE; ORCHIECTOMY; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ANDROGEN; TESTOSTERONE;

EID: 0031891812     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(97)00151-9     Document Type: Article

References (24)

1. Sciarra F., Toscano G., Concolino G., Di Silverio F. Antiandrogens: Clinical applications. J. Steroid Biochem. Molec. Biol. 37:1990;349-362.
2. Tucker H. Non-steroidal antiandrogens in the treatment of prostate cancer. Drugs Future. 15(3):1990;225-265.
3. Neumann, F., Pharmacology and clinical use of cyproterone acetate. In Pharmacology and Clinical Uses of Inhibitors of Hormones Secretion and Action, eds. B. J. A. Furr and A. E. Wakeling. Bailliere Tindall, London, 1987, pp. 132-159.
4. Moguilewsky M., Bouton M. M. How the study of the biological activities of antiandrogens can be oriented towards the clinic. J. Steroid Biochem. 31:1988;699-710.
5. Teutsch G., Goubet F., Battmann T., Bonfils A., Bouchoux F., Cerede E., Gofflo D., Gaillard-Kelly M., Philibert D. New non-steroidal antiandrogens: Synthesis and biological profile of high affinity ligands for the androgen receptor. J. Steroid Biochem. Molec. Biol. 48:1994;111-119.
6. Furr B. J. A. Casodex (ICI 176,334): A new, pure, peripherally-selective antiandrogen: preclinical studies. Horm. Res. 32:1989;69-76.
7. Harris M. G., Coleman S. G., Faulds D., Chrisp P. Nilutamide: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in prostate cancer. Drugs and Aging. 3:1993;9-25.
8. Neri R., Peets E., Watnick A. Antiandrogenicity of flutamide and its metabolite Sch 16423. Biochem. Soc. Trans. 7:1979;565-569.
9. Simard J., Luthy I., Guay J., Bélanger A., Labrie F. Characteristics of interaction of the antiandrogen flutamide with the androgen receptor in various target tissues. Molecular and Cellular Endocrinology. 44:1986;261-270.
10. Battmann T., Bonfils A., Branche C., Humbert J., Goubet F., Teutsch G., Philibert D. RU 58841, a new specific topical antiandrogen: A candidate of choice for the treatment of acne, androgenetic alopecia and hirsutism. J. Ster. Biochem. Molec. Biol. 48(1):1994;55-60.
11. Ojasoo T., Raynaud J. P. Unique steroid congeners for receptor studies. Cancer Res. 38:1978;4186-4198.
12. Raynaud J. P., Bonne C., Bouton M. M., Moguilewsky M., Philibert D., Azadian-Boulanger G. Screening for anti-hormones by receptor studies. J. Steroid. Biochem. 6:1975;615-622.
13. Parker M. G., Webb P., Needham M., White R., Ham J. Identification of androgen response elements in mouse mammary tumor virus and the rat prostate C3 gene. J. Cell. Biochem. 35:1987;285-292.
14. Cato A. C., Henderson D., Ponta H. The hormone response element of the mouse mammary tumour virus DNA mediates the progestin and androgen induction of transcription in the proviral long terminal repeat region. Eur. Mol. Biol. Organ. J. 6:1987;363-368.
15. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Analytical Biochemistry. 72:1976;248-254.
16. Fuhrmann U., Bengston C., Repenthin G., Schillinger E. Stable transfection of androgen receptor and MMTV-CAT into mammalian cells: Inhibition of CAT expression by antiandrogens. J. Steroid Biochem. 42:1992;787-793.
17. Korenchevsky V. The influence of cryptorchidism and castration on body weight, fat deposition and the sexual and endocrine organs of male rats. J. Path. Bacteriol. 33:1950;607-636.
18. Neumann F., Toper M. Pharmacology of antiandrogens. J. Steroid Biochem. 25(5B):1986;885-895.
19. Cousty-Berlin D., Bergaud B., Bruyant M. C., Battmann T., Branche C., Philibert D. Preliminary pharmacokinetics and metabolism of novel non-steroidal antiandrogen in the rat: Relation of their systemic activity to the formation of a common metabolite. J. Steroid Biochem. Molec. Biol. 51:1994;47-55.
20. Davies P., Eaton C. L. Regulation of prostate growth. Journal of Endocrinology. 131:1991;5-17.
21. Brendler C. B., Berry S. J., Ewing L. L., McCullouch A. R., Cochran R. C., Strandberg J. D., Zirkin B. R., Wheaton L. G., Hiler M. L., Bordy M. J., Niswender G. D., Scott W. W., Walsh P. C. Spontaneous benign prostatic hyperplasia in the beagle. Age-associated changes in serum hormone levels, and the morphology and secretatory function of the canine prostate. J. Clin. Invest. 71:1983;114-1123.
22. Juniewicz P. E., McCarthy M., Lemp B. M., Barbolt T. A., Shaw C., Hollenbaugh D. M., Winneker R. C., Reel J. R., Batzold F. H. The effect of the steroidal androgen receptor antagonist, Win 49,596, on the prostate and testis of beagle dogs. Endocrinology. 126:1990;2625-2634.
23. Takezawa Y., Ito K., Suzuki K., Fukabori Y., Yamanaka H., Honma S., Mieda M., Hamataki N., Kushitani M. Effect of a new steroidal antiandrogen TZP-4238 (17α-acetoxy-6-chloro-2-oxa-4, 6-pregnadiene-3,20-dione), on spontaneously developed canine benign prostatic hyperplasia. The Prostate. 27:1995;321-328.
24. Habenichit U. F., Schwarz K., Schweikert H. U., Neumann F., Etreby M. E. Development of a model for the induction of estrogen-released prostatic hyperplasia in the dog and its response to the aromatase inhibitor 4-hydroxy 4-androstene-3,27-dione: Preliminary results. Prostate. 8:1986;181-194.